Catalyst Wire Dossier Catalyst Wire Dossier

NovoSeven

recombinant coagulation factor VIIa · Novo Nordisk
Drug timelines are a Plus or Pro feature.

49 regulatory and trial events tracked for NovoSeven, covering 2006-10-19 to 2024-07-19. Get the full timeline:

Most recent: Clinical Trial Update: SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment [Phase 1, Phase 2]

See pricing